Evidence suggests that high concentrations of fatty acids and glucose in obesity trigger glucolipotoxic responses that gradually impair the ability of β-cell to provide insulin due to dedifferentiation or altered mass, which is a hallmark of late-stage type 2 diabetes mellitus [281, 282]. Here, INS is linked to obesity disorder.